Cliff Asness’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $702M | Sell |
1,126,080
-104,928
| -9% | -$71.4M | 0.24% | 75 |
|
|
2026
Q1 | $946M | Buy |
1,231,008
+235,298
| +24% | +$180M | 0.43% | 29 |
|
|
2025
Q4 | $769M | Buy |
995,710
+274,356
| +38% | +$186M | 0.4% | 37 |
|
|
2025
Q3 | $406M | Buy |
721,354
+606,612
| +529% | +$343M | 0.26% | 72 |
|
|
2025
Q2 | $59.7M | Sell |
114,742
-121,208
| -51% | -$67.7M | 0.05% | 489 |
|
|
2025
Q1 | $149M | Buy |
235,950
+28,865
| +14% | +$19.9M | 0.15% | 173 |
|
|
2024
Q4 | $147M | Sell |
207,085
-18,449
| -8% | -$15.5M | 0.19% | 133 |
|
|
2024
Q3 | $235M | Buy |
225,534
+36,243
| +19% | +$40.3M | 0.32% | 54 |
|
|
2024
Q2 | $199M | Buy |
189,291
+6,839
| +4% | +$6.63M | 0.3% | 65 |
|
|
2024
Q1 | $175M | Sell |
182,452
-13,429
| -7% | -$12.8M | 0.3% | 75 |
|
|
2023
Q4 | $172M | Buy |
195,881
+5,712
| +3% | +$4.7M | 0.32% | 65 |
|
|
2023
Q3 | $157M | Sell |
190,169
-29,481
| -13% | -$23.2M | 0.32% | 63 |
|
|
2023
Q2 | $155M | Sell |
219,650
-21,124
| -9% | -$16.3M | 0.33% | 64 |
|
|
2023
Q1 | $198M | Sell |
240,774
-68,381
| -22% | -$51.6M | 0.43% | 38 |
|
|
2022
Q4 | $221M | Sell |
309,155
-121,146
| -28% | -$89.4M | 0.5% | 31 |
|
|
2022
Q3 | $296M | Sell |
430,301
-120,115
| -22% | -$75.6M | 0.72% | 18 |
|
|
2022
Q2 | $323M | Buy |
550,416
+41,635
| +8% | +$27.1M | 0.73% | 15 |
|
|
2022
Q1 | $355M | Buy |
508,781
+59,162
| +13% | +$37.4M | 0.67% | 14 |
|
|
2021
Q4 | $284M | Buy |
449,619
+173,586
| +63% | +$107M | 0.51% | 31 |
|
|
2021
Q3 | $167M | Buy |
276,033
+81,918
| +42% | +$50.9M | 0.31% | 68 |
|
|
2021
Q2 | $106M | Sell |
194,115
-96,546
| -33% | -$48.9M | 0.18% | 130 |
|
|
2021
Q1 | $138M | Sell |
290,661
-63,244
| -18% | -$30.8M | 0.22% | 108 |
|
|
2020
Q4 | $167M | Sell |
353,905
-111,199
| -24% | -$60M | 0.3% | 74 |
|
|
2020
Q3 | $260M | Buy |
465,104
+103,282
| +29% | +$62.6M | 0.44% | 43 |
|
|
2020
Q2 | $223M | Sell |
361,822
-23,706
| -6% | -$13.5M | 0.36% | 58 |
|
|
2020
Q1 | $179M | Buy |
385,528
+42,468
| +12% | +$17.5M | 0.3% | 76 |
|
|
2019
Q4 | $129M | Buy |
343,060
+48,009
| +16% | +$16.2M | 0.15% | 178 |
|
|
2019
Q3 | $81.2M | Sell |
295,051
-55,846
| -16% | -$16.5M | 0.1% | 258 |
|
|
2019
Q2 | $110M | Sell |
350,897
-32,960
| -9% | -$11M | 0.12% | 205 |
|
|
2019
Q1 | $157M | Buy |
383,857
+152,469
| +66% | +$62.8M | 0.17% | 165 |
|
|
2018
Q4 | $86.4M | Buy |
231,388
+47,207
| +26% | +$17.3M | 0.1% | 223 |
|
|
2018
Q3 | $74.4M | Buy |
184,181
+71,623
| +64% | +$27.3M | 0.07% | 290 |
|
|
2018
Q2 | $38.8M | Sell |
112,558
-178,740
| -61% | -$55.9M | 0.04% | 463 |
|
|
2018
Q1 | $100M | Buy |
291,298
+197,650
| +211% | +$68.7M | 0.11% | 227 |
|
|
2017
Q4 | $35.2M | Buy |
93,648
+45,447
| +94% | +$18.4M | 0.04% | 476 |
|
|
2017
Q3 | $21.6M | Buy |
48,201
+42,577
| +757% | +$20.3M | 0.03% | 573 |
|
|
2017
Q2 | $2.76M | Sell |
5,624
-3,181
| -36% | -$1.39M | ﹤0.01% | 1258 |
|
|
2017
Q1 | $3.41M | Buy |
8,805
+5,884
| +201% | +$2.18M | ﹤0.01% | 1168 |
|
|
2016
Q4 | $1.07M | Sell |
2,921
-531
| -15% | -$202K | ﹤0.01% | 1671 |
|
|
2016
Q3 | $1.39M | Buy |
3,452
+1,167
| +51% | +$468K | ﹤0.01% | 1586 |
|
|
2016
Q2 | $798K | Sell |
2,285
-8,806
| -79% | -$3.39M | ﹤0.01% | 1694 |
|
|
2016
Q1 | $4M | Sell |
11,091
-34,259
| -76% | -$14.1M | 0.01% | 952 |
|
|
2015
Q4 | $24.6M | Buy |
45,350
+24,164
| +114% | +$13.1M | 0.04% | 499 |
|
|
2015
Q3 | $9.85M | Buy |
21,186
+4,382
| +26% | +$2.35M | 0.02% | 631 |
|
|
2015
Q2 | $8.57M | Buy |
16,804
+3,157
| +23% | +$1.54M | 0.02% | 661 |
|
|
2015
Q1 | $6.16M | Buy |
13,647
+4,974
| +57% | +$2.11M | 0.01% | 712 |
|
|
2014
Q4 | $3.56M | Buy |
8,673
+2,734
| +46% | +$1.08M | 0.01% | 1032 |
|
|
2014
Q3 | $2.14M | Sell |
5,939
-11,100
| -65% | -$3.72M | 0.01% | 1225 |
|
|
2014
Q2 | $4.81M | Sell |
17,039
-15,000
| -47% | -$4.45M | 0.01% | 916 |
|
|
2014
Q1 | $9.62M | Sell |
32,039
-2,600
| -8% | -$801K | 0.03% | 607 |
|
|
2013
Q4 | $9.53M | Sell |
34,639
-8,077
| -19% | -$2.32M | 0.03% | 617 |
|
|
2013
Q3 | $13.4M | Buy |
42,716
+11,305
| +36% | +$2.97M | 0.05% | 464 |
|
|
2013
Q2 | $7.06M | Buy |
+31,411
| New | +$7.31M | 0.03% | 715 |
|
Other funds holding REGN
Cliff Asness's REGN Position: Q2 2026 in Review
Cliff Asness reduced its Regeneron Pharmaceuticals (REGN) stake by 8.5% in Q2 2026, selling an estimated $71.4M and leaving 1,126,080 shares worth $702M. The position accounts for 0.24% of the portfolio, ranked #75.
Cliff Asness first reported a position in REGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $946M in Q1 2026. 1,328 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Cliff Asness held 1,126,080 shares of Regeneron Pharmaceuticals worth $702M as of Q2 2026.
- Cliff Asness sold 104,928 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $71.4M.
- Regeneron Pharmaceuticals made up 0.24% of Cliff Asness's portfolio in Q2 2026, its #75 holding.
- Cliff Asness first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- Cliff Asness's Regeneron Pharmaceuticals position peaked at $946M in Q1 2026.
- 1,328 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.